Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2012
10/30/2012US8299029 Stabilised solid compositions of factor VII polypeptides
10/30/2012US8299028 Chimeric peptide antagonist for GPCR135 or GPCR142
10/30/2012US8299027 Method of modulating cell survival and reagents useful for same
10/30/2012US8299026 Derivatisation of erythropoietin (EPO)
10/30/2012US8299025 glucagon-like peptide-1; osmotic drug delivery device and method
10/30/2012US8299024 Methods to restore glycemic control
10/30/2012US8299023 Neuropeptide-2 receptor (Y-2R) agonists
10/30/2012US8299022 Analogs of ghrelin substituted at the N-terminal
10/30/2012US8299021 Macrocyclic inhibitors of hepatitis C virus replication
10/30/2012US8299020 Antimicrobial peptides and methods of their use
10/30/2012US8299019 Uses of modified ELR-CXC chemokine G31P to treat cancer
10/30/2012US8299018 Proteins with an attached short peptide of acidic amino acids
10/30/2012US8299017 Use of tight junction antagonists to treat inflammatory bowl disease
10/30/2012US8299016 ILT3 polypeptides and uses thereof
10/30/2012US8299015 Derivatisation of granulocyte colony-stimulating factor
10/30/2012US8298821 p185neu-encoding DNA and therapeutical uses thereof
10/30/2012US8298812 Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporters
10/30/2012US8298804 Preparation and use of biofilm-degrading, multiple-specificity, hydrolytic enzyme mixtures
10/30/2012US8298801 Human ribonuclease for use in prevention and treatment of cancer; antitumor agents
10/30/2012US8298799 Hydrolases, nucleic acids encoding them and methods for making and using them
10/30/2012US8298776 Antibodies to tumor associated proteins
10/30/2012US8298771 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
10/30/2012US8298769 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
10/30/2012US8298584 Biopolymeric membrane for wound protection and repair
10/30/2012US8298583 Film delivery system for tetrahydrolipstatin
10/30/2012US8298562 Sustained delivery of an active agent using an implantable system
10/30/2012US8298551 Streptococcus pyogenes antigens and corresponding DNA fragments
10/30/2012US8298537 Concomitant treatment of rheumatoid arthritis with anti-TNF-α antibodies and methotrexate
10/30/2012US8298534 Method of treating fibrproliferative disorders
10/30/2012US8298529 Compositions and method for epigenetic modification of nucleic acid sequences in vivo
10/30/2012US8298525 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist
10/30/2012US8298524 Methods of using IL-31 to treat chronic obstructive pulmonary disease (COPD)
10/30/2012US8298523 Compositions containing interleukin-1 and peptides
10/30/2012US8298521 Treatment for eye disorder
10/30/2012CA2683318C Diazo bicyclic smac mimetics and the uses thereof
10/30/2012CA2675528C Oral disinfectant, and food additive comprising the disinfectant
10/30/2012CA2595038C Modified tie-2 receptor ligands
10/30/2012CA2549185C Peptide inhibiting angiotensin converting enzyme
10/30/2012CA2506244C Methods for inhibiting viral replication in vivo
10/30/2012CA2498731C .beta.-l-2'-deoxynucleosides for the treatment of resistant hbv strains and combination therapies
10/30/2012CA2445938C Hepatitis c inhibitor tri-peptides
10/30/2012CA2399790C Cd40 ligand adjuvant for respiratory syncytial virus
10/30/2012CA2360106C Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
10/30/2012CA2230111C Antisecretory factor peptides regulating pathological permeability changes
10/30/2012CA2215161C Proteinase k resistant surface protein of neisseria meningitidis
10/26/2012WO2012145758A1 Fusion peptide designed to reduce plaque bacteria and yeast in the oral cavity
10/26/2012WO2012145743A1 Microrna-140-5p as a tumor suppressor and sensitizing agent for chemotherapy
10/26/2012WO2012145680A2 Anti-microbial peptides and uses therefore
10/26/2012WO2012145665A2 Method of drug delivery for pth, pthrp and related peptides
10/26/2012WO2012145651A2 Compounds for the treatment of neuropsychiatric disorders
10/26/2012WO2012145644A1 Modified acid alpha glucosidase with accelerated processing
10/26/2012WO2012145630A2 Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
10/26/2012WO2012145523A2 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity
10/26/2012WO2012145509A2 Adeno-associated-virus rep sequences, vectors, and viruses
10/26/2012WO2012145428A2 Altering protein concentrations in cerebrospinal fluid and/or brain interstitial fluid
10/26/2012WO2012145427A1 Methods to treat cancer using cyclosporine and cyclosporine derivatives
10/26/2012WO2012145384A1 Beta-2 microglobulin-deficient cells
10/26/2012WO2012145369A1 Compositions and methods for nutritional supplementation
10/26/2012WO2012144972A2 Methods to inhibit neurodegeneration
10/26/2012WO2012144912A1 A method of peptide hydrolysis, peptidase, the composition for use as a bacteriostatic and bactericidal agent, a kit and the uses of the active form of lytm from s. aureus or derivatives thereof
10/26/2012WO2012144778A2 Surface-active collagen barrier membrane to which a peptide is bound
10/26/2012WO2012144726A2 Tumor antigen proteins or genes of polo-like kinase 1
10/26/2012WO2012144719A1 Surface-active collagen membrane by peptide
10/26/2012WO2012144546A1 Novel peptide
10/26/2012WO2012144535A1 Acute hepatic insufficiency depressant and method for evaluating drug efficacy thereof
10/26/2012WO2012144501A1 Anti-allergy substance, anti-allergy agent, and food
10/26/2012WO2012144446A1 Drug delivery particles and method for producing same
10/26/2012WO2012143868A1 Suspension type topical formulations comprising cyclic depsipeptide
10/26/2012WO2012143488A1 Protein for use as a medicament
10/26/2012WO2012143483A1 Method for preparing a concentrate of factor xi
10/26/2012WO2012143418A1 STABLE PHARMACEUTICAL LIQUID FORMULATIONS OF THE FUSION PROTEIN TNFR:Fc
10/26/2012WO2012143362A1 Infant formula for use in the prevention of cardiovascular diseases
10/26/2012WO2012143324A1 Cartilage product
10/26/2012WO2012143020A1 Multiple interferon and virus response element cell-based fluorescence system
10/26/2012WO2012142961A1 Glycoprotein composition with low residual solvent level, and preparation method and use thereof
10/26/2012WO2012142959A1 High purity of caspofungin or salts thereof, and preparation method therefor, and use thereof
10/26/2012WO2012142930A1 Anti-fatty acid synthase polypeptide and use thereof
10/26/2012WO2012142855A1 Antibiotic peptide and preparation method therefor and application thereof
10/26/2012WO2012142773A1 Use of il-4 in the manufacture of medicaments for treating severe hepatitis
10/26/2012WO2012142706A1 Growth hormone releasing factor (grf) analogs and uses thereof
10/26/2012WO2012142696A1 Locally-active anticoagulants and anti-inflammatory agents
10/26/2012WO2012142659A1 Site-selective modification of proteins
10/26/2012WO2012116357A3 Use of agr3 for treating cancer
10/26/2012WO2012115940A3 A method of inducing hematopoietic reconstruction
10/26/2012WO2012115439A9 Composition comprising expression or activity regulators of akap12 for treating central nerve system diseases
10/26/2012WO2012112767A3 Collagen-targeted nanoparticles
10/26/2012WO2012112007A3 Composition containing inducer of sirt1 expression for preventing or treating sepsis or septic shock
10/26/2012WO2012104550A3 INHIBITORS OF THE INTERACTION OF THE SIGMA-1 RECEPTOR WITH hERG FOR USE IN THE TREATMENT OF CANCER
10/26/2012WO2012099940A3 Methods and compositions for treating ocular disease
10/26/2012WO2012097344A3 Metal abstraction peptide and uses thereof
10/26/2012WO2012096926A3 Method for delivering agents into cells using bacterial toxins
10/26/2012WO2012094679A3 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors
10/26/2012WO2012082942A3 Neuropeptide analogs, compositions, and methods for treating pain
10/26/2012WO2012075490A3 Anti-podoplanin antibodies and methods of use
10/26/2012WO2012074966A3 Improved production of anti-peptide antibodies
10/26/2012WO2012031250A8 Compositions for labeling nerves and methods of use
10/26/2012WO2012028525A3 Method for producing a tetranectin-apolipoprotein a-i particle, the lipid particle obtained therewith and its use
10/26/2012WO2012019299A9 Hepatitis c inhibitor compounds
10/26/2012WO2012018948A3 Combination therapy for the treatment of prostate carcinoma
10/26/2012WO2011113005A8 Compositions and methods for combinations of oligoamines with 2-difluoromethylornithine (dfmo)
1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 3163